Resolution to Approve the Prothena Business Demerger Passed at Elan EGM

DUBLIN--(BUSINESS WIRE)-- Elan Corporation, plc (NYS: ELN) announces that, at an Extraordinary General Meeting (EGM) held earlier today, the sole ordinary resolution to approve the demerger of the Prothena Business was duly passed. The full text of the resolution was included in the notice of the EGM dated November 12, 2012 which is available on the Company's website. The details of the votes lodged by proxy are also available on

About Elan

Elan Corporation, plc (NYS: ELN) is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York and Irish Stock Exchanges. For additional information about the Company, please visit



Investor Relations:
Chris Burns
Ph: 1-800-252-3526
David Marshall
Ph: + 353-1-709-4444
Media Relations:
Emer Reynolds
Ph: + 353-1-709-4022
Jonathan Birt
Ph: + 44-751-559-7858

KEYWORDS:   United States  Europe  North America  New York  Ireland


The article Resolution to Approve the Prothena Business Demerger Passed at Elan EGM originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Increase your money and finance knowledge from home

Managing your Portfolio

Keeping your portfolio and financial life fit!

View Course »

Understanding Stock Market Indexes

What does it mean when people say "the market is up 2%"?

View Course »